The global microarray analysis market size is expected to grow from USD 3.97 billion in 2020 to USD 5.36 billion by 2026 at a CAGR of 5.1%.
DNA microarrays are used to diagnose various types of cancer. As a result, the global cancer epidemic is expected to support the growth of the microarray analysis market during the forecast period. According to the WHO, cancer is the second leading cause of death in the world and is estimated at 8.8 million deaths in 2015. And, globally, cancer cases are expected to increase to 21.7 million by 2030. Microarray technology is widely used in genome mapping and sequencing applications. However, over the past few years, these technologies have become increasingly used in the diagnosis and treatment of genetic diseases, drug discovery, pharmacogenomic research, cancer diagnosis, and forensic use. In addition, microarray technology is also used in immunology studies such as research on phenotype and gene expression, activation and differentiation of immune cells, regulation of immune responses, analysis of allergic cell processes, and immunology pharmacology.
By product and service, the market is divided into consumables, software & services, instruments. In 2020, the consumables segment is estimated to command the largest share in the market for microarray analysis. A large share of this category can be attributed to growing microarray applications in a variety of fields as well as regular, repetitive, and commercial purchases.
By type, the market is divided into DNA microarrays, protein microarrays, and other microarrays. DNA microarrays segment is expected to account for the largest share in the microarray analysis market in 2020. This is due to the use of DNA microarrays in various applications such as drug discovery, genomics and cancer research, self-medication, and genetic testing.
By application, the market is divided into research applications, disease diagnostics, drug discovery, and other applications. In 2020, the research applications segment is expected to account for the largest share in the market. Adding independent and government funding for genomic and proteomic research is the most important driving force in this market.
The end-user segment is divided into research and academic institutes, pharmaceutical and biotechnology companies, diagnostic laboratories, and other end users. In 2020, the research and academic institutes segment is expected to hold the largest market share. Increasing funding and growing government programs to fund Genomics and Proteomics research projects is an important factor contributing to the growth of the research component and educational institutions.
The market is dominated by North America, followed by Europe. North America will continue to control the market during the forecast period. The proliferation of various diseases such as cancer and genetic diseases in the region and the increase in funding for genomics and proteomics research in the region are the main factors supporting the growth of microarray market analysis in North America.
The major players operating in the microarray analysis market are Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), Illumina, Inc. (US), PerkinElmer Inc. (US), GE Healthcare (US), Molecular Devices (US), and Bio-Rad Laboratories Inc. (US).